NCT Number: NCT00274430
Prevention of High Altitude Pulmonary Edema
A double-blind placebo controlled study
* To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE. * To investigate the effect of dexamethasone on alveolar fluid clearance, as assessed by measurement of the nasal potential difference, and prevention of HAPE. * To investigate the effect of the tadalafil and dexamethasone versus placebo on the dynamic CBF autoregulation properties and on the development of AMS in HAPE susceptible subjects.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–60 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1 / Phase 2
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- At least one previous episode of high altitude pulmonary edema
Exclusion criteria
- pulmonary arterial hypertension
- congenital heart disease
- any chronic lung disease
Treatment and study plan
tadalafil 10mg bid
DrugPrimary outcomes
-
prevention of high altitude pulmonary edema
Secondary outcomes
-
incidence of acute mountain sickness
Sponsors and collaborators
Lead sponsor
University of Zurich
Other
Registry information
Official study title
A Randomized Controlled Trial of the Effects of Tadalafil and Dexamethasone Versus Placebo on Pulmonary Edema Formation and Cerebral Blood Flow Autoregulation in High Altitude Newcomers With a Previous History of High Altitude Pulmonary Edema
Important dates
- Study start
- 2003
- Study completion
- 2003
- First posted
- Jan 10, 2006
- Registry last updated
- Dec 4, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Risk Factors Associated With High Altitude Sickness: A Case-Control Study
NCT06039475
Acute Mountain Sickness, Altitude Sickness
Jomsom, Gandaki, Nepal
View Trial DetailsEvaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema
NCT04186598
Altitude Sickness, Continuous Positive Airway Pressure
Breckenridge, Colorado, United States
View Trial DetailsSusceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction
NCT00559442
Altitude Sickness, High Altitude Pulmonary Edema
Heidelberg, Germany
View Trial DetailsRandomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness
NCT00627965
Acute Mountain Sickness, Altitude Sickness
View Trial Details